
    
      A randomized clinical controlled trial of women undergoing IUD insertion. Participants in the
      study groups will be randomly assigned by labeled opaque envelopes to either1% lidocaine
      (Xylocaine 1%, Astra Zeneca, Egypt), misoprostol (Sigma, Egypt), naproxen (Naprosyn, Syntax,
      Egypt) or placebo tablets.
    
  